If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
| pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
drug response |
not provided |
total |
|
578
|
235
|
6340
|
4627
|
444
|
2
|
95
|
10944
|
Condition and significance breakdown #
| Condition |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
drug response |
not provided |
total |
|
not provided
|
558
|
191
|
4881
|
3493
|
233
|
0 |
7
|
9059
|
|
Hereditary cancer-predisposing syndrome
|
4
|
1
|
3543
|
2275
|
100
|
0 |
0 |
5819
|
|
not specified
|
0 |
0 |
386
|
677
|
120
|
0 |
0 |
1097
|
|
Colorectal cancer, susceptibility to, 12
|
7
|
15
|
353
|
212
|
233
|
0 |
3
|
798
|
|
Colorectal cancer, susceptibility to, 12; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome; Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
|
0 |
1
|
237
|
63
|
8
|
0 |
0 |
309
|
|
POLE-related disorder
|
1
|
13
|
126
|
126
|
4
|
0 |
0 |
270
|
|
Familial colorectal cancer type X; Polymerase proofreading-related adenomatous polyposis
|
1
|
0 |
41
|
29
|
6
|
0 |
0 |
77
|
|
Polymerase proofreading-related adenomatous polyposis
|
0 |
1
|
40
|
23
|
5
|
0 |
1
|
70
|
|
Colorectal cancer, susceptibility to, 12; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome
|
1
|
0 |
41
|
1
|
0 |
0 |
13
|
56
|
|
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome
|
6
|
5
|
21
|
0 |
14
|
0 |
0 |
46
|
|
Carcinoma of colon
|
2
|
0 |
11
|
16
|
7
|
0 |
0 |
36
|
|
POLE-related polyposis and colorectal cancer syndrome
|
0 |
2
|
3
|
21
|
5
|
0 |
1
|
32
|
|
Familial colorectal cancer
|
0 |
0 |
25
|
4
|
0 |
0 |
0 |
29
|
|
Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
|
7
|
4
|
4
|
0 |
14
|
0 |
0 |
29
|
|
Familial colorectal cancer type X
|
0 |
0 |
16
|
10
|
0 |
0 |
0 |
26
|
|
Colorectal cancer, susceptibility to, 10
|
0 |
0 |
14
|
5
|
0 |
0 |
0 |
19
|
|
Hereditary cancer
|
0 |
0 |
1
|
18
|
0 |
0 |
0 |
19
|
|
Uterine corpus endometrial carcinoma
|
0 |
0 |
0 |
0 |
0 |
0 |
15
|
15
|
|
Colorectal cancer
|
1
|
3
|
5
|
0 |
0 |
0 |
2
|
11
|
|
Familial colorectal cancer; Facial dysmorphism-immunodeficiency-livedo-short stature syndrome
|
0 |
0 |
0 |
0 |
0 |
0 |
10
|
10
|
|
Malignant tumor of breast
|
0 |
0 |
7
|
0 |
3
|
0 |
0 |
10
|
|
Ovarian serous cystadenocarcinoma
|
0 |
0 |
0 |
0 |
0 |
0 |
10
|
10
|
|
Gastric cancer
|
0 |
0 |
0 |
0 |
0 |
0 |
8
|
8
|
|
Acute myeloid leukemia
|
0 |
0 |
0 |
0 |
0 |
0 |
7
|
7
|
|
Familial cancer of breast
|
0 |
0 |
1
|
0 |
0 |
0 |
6
|
7
|
|
Cervical cancer
|
0 |
0 |
0 |
0 |
0 |
0 |
6
|
6
|
|
Lung cancer
|
0 |
0 |
0 |
0 |
0 |
0 |
6
|
6
|
|
Thyroid cancer, nonmedullary, 1
|
0 |
0 |
0 |
0 |
0 |
0 |
6
|
6
|
|
Malignant lymphoma, large B-cell, diffuse
|
0 |
0 |
0 |
0 |
0 |
0 |
5
|
5
|
|
Malignant tumor of esophagus
|
0 |
0 |
0 |
0 |
0 |
0 |
5
|
5
|
|
Neoplasm
|
0 |
4
|
1
|
0 |
0 |
0 |
0 |
5
|
|
Melanoma
|
0 |
1
|
0 |
0 |
0 |
0 |
3
|
4
|
|
Thymoma
|
0 |
0 |
0 |
0 |
0 |
0 |
4
|
4
|
|
Cholangiocarcinoma
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
3
|
|
Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Facial dysmorphism-immunodeficiency-livedo-short stature syndrome; Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency
|
0 |
2
|
1
|
0 |
0 |
0 |
0 |
3
|
|
Papillary renal cell carcinoma type 1
|
0 |
0 |
0 |
0 |
0 |
0 |
3
|
3
|
|
Colon adenocarcinoma
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Diffuse midline glioma, H3 K27-altered
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
Familial ovarian cancer
|
1
|
0 |
0 |
1
|
0 |
0 |
0 |
2
|
|
Hepatocellular carcinoma
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Inherited polyposis and early onset colorectal cancer - germline testing
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
Malignant tumor of urinary bladder
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Nonpapillary renal cell carcinoma
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Pediatric high-grade glioma
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
Programmed death ligand-1 (PD-L1) blocking antibody response
|
0 |
0 |
0 |
0 |
0 |
2
|
0 |
2
|
|
Sarcoma
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Squamous cell carcinoma of the head and neck
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Squamous cell lung carcinoma
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Uterine carcinosarcoma
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Adenocarcinoma of the large intestine
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Cancer or benign tumor
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Colon cancer
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Colorectal cancer susceptibility 12
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Colorectal cancer, susceptibility to, 12; Polymerase proofreading-related adenomatous polyposis
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
|
Colorectal carcinoma
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Cystic fibrosis-gastritis-megaloblastic anemia syndrome
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Endometrial carcinoma
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
|
Endometrioid adenocarcinoma
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Germ cell tumor of testis
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
|
Myoepithelial tumor
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Neuroepithelial neoplasm
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
POLE Exonuclease Domain Mutation
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Uveal melanoma
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
|
XFE progeroid syndrome
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
| Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
drug response |
not provided |
total |
|
Labcorp Genetics (formerly Invitae), Labcorp
|
560
|
162
|
4686
|
3349
|
120
|
0 |
0 |
8877
|
|
Ambry Genetics
|
3
|
0 |
3508
|
2215
|
56
|
0 |
0 |
5782
|
|
GeneDx
|
4
|
28
|
963
|
588
|
124
|
0 |
0 |
1707
|
|
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
|
5
|
9
|
232
|
375
|
47
|
0 |
0 |
667
|
|
Quest Diagnostics Nichols Institute San Juan Capistrano
|
0 |
0 |
270
|
85
|
107
|
0 |
0 |
462
|
|
Department of Pathology and Laboratory Medicine, Sinai Health System
|
5
|
1
|
210
|
147
|
37
|
0 |
0 |
400
|
|
PreventionGenetics, part of Exact Sciences
|
1
|
12
|
157
|
169
|
58
|
0 |
0 |
397
|
|
Myriad Genetics, Inc.
|
0 |
0 |
13
|
95
|
161
|
0 |
0 |
269
|
|
Fulgent Genetics, Fulgent Genetics
|
1
|
0 |
192
|
22
|
3
|
0 |
0 |
218
|
|
Sema4, Sema4
|
0 |
0 |
52
|
111
|
46
|
0 |
0 |
209
|
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
6
|
1
|
65
|
57
|
74
|
0 |
0 |
203
|
|
CeGaT Center for Human Genetics Tuebingen
|
2
|
3
|
45
|
113
|
9
|
0 |
0 |
172
|
|
Counsyl
|
0 |
1
|
63
|
70
|
12
|
0 |
0 |
146
|
|
Breakthrough Genomics, Breakthrough Genomics
|
0 |
0 |
16
|
54
|
74
|
0 |
0 |
144
|
|
Mendelics
|
0 |
0 |
69
|
52
|
3
|
0 |
0 |
124
|
|
KCCC/NGS Laboratory, Kuwait Cancer Control Center
|
0 |
1
|
6
|
24
|
73
|
0 |
0 |
104
|
|
Baylor Genetics
|
0 |
0 |
102
|
0 |
0 |
0 |
0 |
102
|
|
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
|
0 |
1
|
95
|
0 |
0 |
0 |
0 |
96
|
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
|
0 |
0 |
30
|
27
|
36
|
0 |
0 |
93
|
|
Genetic Services Laboratory, University of Chicago
|
0 |
0 |
35
|
26
|
11
|
0 |
0 |
72
|
|
Mayo Clinic Laboratories, Mayo Clinic
|
0 |
0 |
23
|
22
|
25
|
0 |
0 |
70
|
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
|
0 |
0 |
56
|
2
|
9
|
0 |
0 |
67
|
|
Dr. Peter K. Rogan Lab, Western University
|
0 |
0 |
0 |
0 |
0 |
0 |
63
|
63
|
|
True Health Diagnostics
|
1
|
0 |
27
|
33
|
1
|
0 |
0 |
62
|
|
Clinical Genetics, Academic Medical Center
|
0 |
0 |
0 |
16
|
38
|
0 |
0 |
54
|
|
Genome Diagnostics Laboratory, Amsterdam University Medical Center
|
0 |
0 |
0 |
17
|
24
|
0 |
0 |
41
|
|
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
|
1
|
1
|
37
|
0 |
0 |
0 |
0 |
39
|
|
Revvity Omics, Revvity
|
0 |
0 |
30
|
0 |
0 |
0 |
0 |
30
|
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
0 |
25
|
25
|
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
|
0 |
0 |
1
|
2
|
19
|
0 |
0 |
22
|
|
Molecular Pathology, Peter Maccallum Cancer Centre
|
0 |
0 |
14
|
5
|
0 |
0 |
0 |
19
|
|
Genome Diagnostics Laboratory, University Medical Center Utrecht
|
0 |
0 |
0 |
13
|
5
|
0 |
0 |
18
|
|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
|
0 |
0 |
1
|
14
|
2
|
0 |
0 |
17
|
|
MGZ Medical Genetics Center
|
0 |
0 |
16
|
0 |
0 |
0 |
0 |
16
|
|
Clinical Genetics Laboratory, Skane University Hospital Lund
|
0 |
0 |
14
|
1
|
0 |
0 |
0 |
15
|
|
Institute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C.
|
0 |
0 |
2
|
2
|
11
|
0 |
0 |
15
|
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
14
|
0 |
0 |
14
|
|
University of Washington Department of Laboratory Medicine, University of Washington
|
0 |
0 |
3
|
10
|
1
|
0 |
0 |
14
|
|
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
|
0 |
0 |
0 |
7
|
4
|
0 |
0 |
11
|
|
Molecular Diagnostics Laboratory, Catalan Institute of Oncology
|
1
|
1
|
5
|
2
|
1
|
0 |
0 |
10
|
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
1
|
9
|
0 |
0 |
0 |
0 |
10
|
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
0 |
9
|
9
|
|
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
|
3
|
2
|
4
|
0 |
0 |
0 |
0 |
9
|
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
|
0 |
0 |
2
|
5
|
1
|
0 |
0 |
8
|
|
Knight Diagnostic Laboratories, Oregon Health and Sciences University
|
0 |
0 |
8
|
0 |
0 |
0 |
0 |
8
|
|
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
|
0 |
1
|
3
|
2
|
1
|
0 |
0 |
7
|
|
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
|
0 |
0 |
6
|
0 |
0 |
0 |
0 |
6
|
|
GeneKor MSA
|
0 |
0 |
0 |
0 |
6
|
0 |
0 |
6
|
|
OMIM
|
6
|
0 |
0 |
0 |
0 |
0 |
0 |
6
|
|
3billion
|
0 |
2
|
3
|
0 |
0 |
0 |
0 |
5
|
|
CSER _CC_NCGL, University of Washington
|
0 |
0 |
5
|
0 |
0 |
0 |
0 |
5
|
|
Dasa
|
0 |
0 |
0 |
3
|
2
|
0 |
0 |
5
|
|
EVOGEN
|
0 |
5
|
0 |
0 |
0 |
0 |
0 |
5
|
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
|
0 |
0 |
5
|
0 |
0 |
0 |
0 |
5
|
|
Laboratorio de I+D, Fundación Centro Médico de Asturias
|
0 |
0 |
0 |
2
|
3
|
0 |
0 |
5
|
|
Laboratory of Genetics, Children's Clinical University Hospital Latvia
|
0 |
0 |
0 |
3
|
2
|
0 |
0 |
5
|
|
Laboratory of Medical Genetics Unit, Bambino Gesù Children's Hospital
|
0 |
0 |
5
|
0 |
0 |
0 |
0 |
5
|
|
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
|
2
|
1
|
1
|
0 |
0 |
0 |
0 |
4
|
|
Molecular Oncology Laboratory, Hospital Clínico San Carlos
|
0 |
1
|
2
|
1
|
0 |
0 |
0 |
4
|
|
New York Genome Center
|
0 |
1
|
3
|
0 |
0 |
0 |
0 |
4
|
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
|
3
|
0 |
1
|
0 |
0 |
0 |
0 |
4
|
|
Blueprint Genetics
|
0 |
1
|
2
|
0 |
0 |
0 |
0 |
3
|
|
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
|
0 |
0 |
0 |
2
|
1
|
0 |
0 |
3
|
|
Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, Shanghai Jiao Tong University School of Medicine.
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
3
|
|
Division of Medical Genetics, University of Washington
|
0 |
0 |
3
|
0 |
0 |
0 |
0 |
3
|
|
Zotz-Klimas Genetics Lab, MVZ Zotz Klimas
|
0 |
1
|
2
|
0 |
0 |
0 |
0 |
3
|
|
Centre for Translational Omics - GOSgene, University College London
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
2
|
|
Department of Maternal-Fetal Biology, National Research Institute for Child Health and Development
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
2
|
|
Eurofins Ntd Llc (ga)
|
0 |
0 |
1
|
1
|
0 |
0 |
0 |
2
|
|
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
Genetics and Molecular Pathology, SA Pathology
|
0 |
0 |
1
|
1
|
0 |
0 |
0 |
2
|
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
Genomics and Molecular Medicine Service, East Genomic Laboratory Hub, NHS Genomic Medicine Service
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
Institute of Human Genetics, University of Goettingen
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
Institute of Human Genetics, University of Leipzig Medical Center
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
Institute of Immunology and Genetics Kaiserslautern
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
2
|
|
MutSpliceDB: a database of splice sites variants effects on splicing, NIH
|
0 |
0 |
0 |
0 |
0 |
0 |
2
|
2
|
|
Oxford Haemato-Oncology Service, Oxford University Hospitals NHS Foundation Trust
|
0 |
0 |
0 |
0 |
0 |
2
|
0 |
2
|
|
Unidad de Genética Molecular HGU Elche, Hospital General Universitario de Elche
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
2
|
|
3DMed Clinical Laboratory Inc
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
AiLife Diagnostics, AiLife Diagnostics
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Biotechnology, Institute of Science, Nirma University
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Center of Medical Genetics and Primary Health Care
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
Color Diagnostics, LLC DBA Color Health
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Department of Molecular Diagnostics, Institute of Oncology Ljubljana
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Dr. med. U. Finckh, Human Genetics, Eurofins MVZ
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
1
|
|
First Genomix Gene Laboratory, Genetic Diagnostics Department
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Genetic Predisposition to Colorectal Cancer Group, Institut d’Investigacions Biomediques August Pi i Sunyer
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genetics and Genomic Medicine Centre, NeuroGen Healthcare, NeuroGen Healthcare
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genomic Center, National Cancer Institute
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genomic Research Center, Shahid Beheshti University of Medical Sciences
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Gynecological Pathology Laboratory, Kaohsiung Medical University Chung-Ho Memorial Hospital
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Hadassah Hebrew University Medical Center
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Hereditary Cancer Laboratory, Hospital Universitario 12 de Octubre
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
1
|
|
Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Institute of Human Genetics, FAU Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Juno Genomics, Hangzhou Juno Genomics, Inc
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Praxis Für Humangenetik, Biosciencia MVZ Labor Saar
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
1
|
|
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Swedish National ChiCaP Initative, Genomic Medicine Sweden
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
1
|
|
Vantari Genetics
|
0 |
0 |
0 |
0 |
1
|
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. The submitted information has not been verified.
If you have questions about the information contained on this
website, please see a health care professional.